Monday, December 23, 2024
HomeIndustriesHealthcare

Healthcare

Hummingbird Bioscience Announces First Patient Dosed in Phase 1 Clinical Trial of HMBD-001 in Advanced HER3-Expressing Solid Malignancies

Hummingbird Bioscience, an innovative clinical-stage biotech company focused on developing precision therapies against hard-to-drug targets in cancer and autoimmune disease, and Cancer Research UK,...

AIkido Pharma Announces Strategic Interest in ASP Isotopes Inc.

AIkido Pharma Inc. announced that the Company secured a strategic equity interest in ASP Isotopes, Inc., which focuses on the non-nuclear supply of enriched...

Darling Ingredients’ Rousselot® Health Brand Obtains A Granted Patent from the European Patent Office for its SiMoGel™ Solution.

Rousselot, Darling Ingredients' health brand, and the global leader of collagen-based solutions1, announces that the European Patent Office (EPO) has granted the company's patent...

Kazia Announces Positive Final Data From Phase II Clinical Study Of Paxalisib In Newly Diagnosed Glioblastoma

Kazia Therapeutics Limited , an oncology-focused drug development company, is pleased to announce positive final data from a phase II clinical study of paxalisib...

Janssen to Showcase Progress on Respiratory Syncytial Virus (RSV) Vaccine Candidate at ESWI 2021

The Janssen Pharmaceutical Companies of Johnson & Johnson announced it will present data from six company-sponsored studies in support of their respiratory syncytial virus...
0FansLike
0FollowersFollow
spot_img

Hot Topics